Faculty, Staff and Student Publications
Publication Date
4-1-2022
Journal
Journal of Pediatrics
Abstract
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
Keywords
Adolescent, COVID-19, COVID-19 Vaccines, Humans, Myocarditis, RNA, Messenger
DOI
10.1016/j.jpeds.2021.12.025
PMID
34952008
PMCID
PMC8691954
PubMedCentral® Posted Date
December 2021
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes